Price:
Rs. 12,600.00
Sample Type: HEPARIN BLOOD
Fasting Not Required
Notes: C0378
Frequently Asked Questions (FAQ's):
What does the Conventional Karyotyping for CLL test include?
This test evaluates the chromosomes of stimulated B-cells to detect structural or numerical abnormalities associated with CLL.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses B-cell stimulation in culture followed by cytogenetic analysis to accurately identify chromosomal abnormalities in CLL patients.
Who should take this test?
Patients diagnosed with chronic lymphocytic leukemia may be advised to undergo karyotyping for prognostic assessment and treatment planning.
What sample type is required?
A heparinized blood sample is required to maintain viable lymphocytes suitable for chromosomal analysis.
Why is karyotyping important in CLL?
Detecting chromosomal abnormalities helps determine prognosis, guides treatment decisions, and identifies patients at higher risk of disease progression.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows stringent quality protocols, validated cytogenetic methods, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation is required; patients should provide the sample according to physician instructions.
How soon are results available?
Turnaround time may vary due to cell culture and analysis, but Metropolis Healthcare provides results in a timeframe suitable for clinical decision-making.